Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Ghiassian S.D.,,Endophenotype Network Models: Common Core of Complex Diseases,2016,Scientific Reports,36,10.1038/srep27414,United States;United States,Article,Boston;Boston,1,Journal,2-s2.0-84974528500
Suciu L.,,Evaluation of patients diagnosed with essential arterial hypertension through network analysis,2016,Irish Journal of Medical Science,1,10.1007/s11845-015-1342-1,Romania,Article,Timisoara,0,Journal,2-s2.0-84941331889
Sato S.,,Acute inhibition of neurosteroid estrogen synthesis suppresses status epilepticus in an animal model,2016,eLife,35,10.7554/eLife.12917,United States,Article,Evanston,1,Journal,2-s2.0-84968799788
Zahoránszky-Kohalmi G.,,Impact of similarity threshold on the topology of molecular similarity networks and clustering outcomes,2016,Journal of Cheminformatics,8,10.1186/s13321-016-0127-5,United States,Article,Albuquerque,1,Journal,2-s2.0-84966344071
Topirceanu A.,,Data analysis for patients with sleep apnea syndrome: A complex network approach,2016,Advances in Intelligent Systems and Computing,3,10.1007/978-3-319-18296-4_19,Romania,Conference Paper,Timisoara,0,Book Series,2-s2.0-84952333603
Nugent T.,,Computational drug repositioning based on side-effects mined fromsocial media,2016,PeerJ Computer Science,16,10.7717/peerj-cs.46,United States,Article,New York,1,Journal,2-s2.0-84987658065
Cohen P.,,DARPA's Big Mechanism program,2015,Physical Biology,34,10.1088/1478-3975/12/4/045008,United States,Article,Arlington,1,Journal,2-s2.0-84937597394
Zhou B.,,Drug repurposing based on drug-drug interaction,2015,Chemical Biology and Drug Design,6,10.1111/cbdd.12378,China,Article,Wuhan,0,Journal,2-s2.0-84920941625
Shameer K.,,Computational and experimental advances in drug repositioning for accelerated therapeutic stratification,2015,Current Topics in Medicinal Chemistry,41,10.2174/1568026615666150112103510,United States,Article,New York,0,Journal,2-s2.0-84922285922
Jacomy M.,,"ForceAtlas2, a continuous graph layout algorithm for handy network visualization designed for the Gephi software",2014,PLoS ONE,695,10.1371/journal.pone.0098679,France;France;France,Article,Paris;Paris;Paris,1,Journal,2-s2.0-84902603261
Theodoridou S.,,Laboratory investigation of platelet function in patients with thalassaemia,2014,Acta Haematologica,1,10.1159/000355817,United States;Greece,Article,Thessaloniki;Thessaloniki,0,Journal,2-s2.0-84892406148
Graul A.,,"The year's new drugs &amp; biologics, 2013: Part I",2014,Drugs of Today,16,10.1358/dot.2014.50.1.2116673,United States,Review,New York,0,Journal,2-s2.0-84893675072
Topirceanu A.,,Network fidelity: A metric to quantify the similarity and realism of complex networks,2013,"Proceedings - 2013 IEEE 3rd International Conference on Cloud and Green Computing, CGC 2013 and 2013 IEEE 3rd International Conference on Social Computing and Its Applications, SCA 2013",12,10.1109/CGC.2013.53,Romania,Conference Paper,Timisoara,0,Conference Proceeding,2-s2.0-84893224577
Bolgár B.,,Drug repositioning for treatment of movement disorders: From serendipity to rational discovery strategies,2013,Current Topics in Medicinal Chemistry,19,10.2174/15680266113136660164,Hungary,Article,Budapest,0,Journal,2-s2.0-84887899544
Csermely P.,,Structure and dynamics of molecular networks: A novel paradigm of drug discovery: A comprehensive review,2013,Pharmacology and Therapeutics,492,10.1016/j.pharmthera.2013.01.016,Hungary,Review,Budapest,0,Journal,2-s2.0-84877580262
Huang J.,,Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network,2013,PLoS Computational Biology,74,10.1371/journal.pcbi.1002998,China;China;China,Article,Shanghai;Beijing;Shanghai,1,Journal,2-s2.0-84875992866
Liu Z.,,In silico drug repositioning-what we need to know,2013,Drug Discovery Today,95,10.1016/j.drudis.2012.08.005,United States,Short Survey,Jeffersonville,0,Journal,2-s2.0-84873076688
Baxendale S.,,Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures,2012,DMM Disease Models and Mechanisms,82,10.1242/dmm.010090,United Kingdom,Article,Sheffield,1,Journal,2-s2.0-84870028642
Laidlaw T.,,Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes,2012,Blood,137,10.1182/blood-2011-10-384826,United States;United States;United States,Article,Boston;Boston;Boston,1,Journal,2-s2.0-84860322842
Tatonetti N.,,Data-driven prediction of drug effects and interactions,2012,Science Translational Medicine,283,10.1126/scitranslmed.3003377,United States,Article,Palo Alto,0,Journal,2-s2.0-84858329412
Karlgren M.,,In Vitro and in silico strategies to identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions,2012,Pharmaceutical Research,81,10.1007/s11095-011-0564-9,Sweden,Article,Uppsala,1,Journal,2-s2.0-84859346272
Cheng C.Y.,,Cisplatin-induced acute hyponatremia leading to a seizure and coma: A case report,2011,Chang Gung Medical Journal,9,,Taiwan,Article,Taoyuan,0,Journal,2-s2.0-84865085078
Takarabe M.,,Network-based analysis and characterization of adverse drug-drug interactions,2011,Journal of Chemical Information and Modeling,44,10.1021/ci200367w,Japan,Article,Kyoto,0,Journal,2-s2.0-82355160710
Shardlow C.,,Utilizing drug-drug interaction prediction tools during drug development: Enhanced decision making based on clinical risk,2011,Drug Metabolism and Disposition,23,10.1124/dmd.111.039214,United Kingdom,Article,Brentford,0,Journal,2-s2.0-80054734196
Pammolli F.,,The productivity crisis in pharmaceutical R&amp;D,2011,Nature Reviews Drug Discovery,534,10.1038/nrd3405,Italy,Article,Lucca,0,Journal,2-s2.0-79957889347
Polasek T.,,Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: A criteria-based assessment,2011,British Journal of Clinical Pharmacology,55,10.1111/j.1365-2125.2011.03903.x,Australia,Article,Adelaide,0,Journal,2-s2.0-79953865813
Shaughnessy A.,,"Old drugs, new tricks",2011,BMJ,24,10.1136/bmj.d741,United States,Short Survey,Medford,0,Journal,2-s2.0-79951616214
Lewis L.,,Drug-drug interactions: Is there an optimal way to study them?,2010,British Journal of Clinical Pharmacology,18,10.1111/j.1365-2125.2010.03829.x,United States,Editorial,Lebanon,0,Journal,2-s2.0-78349250980
Kunegis J.,,Network growth and the spectral evolution model,2010,"International Conference on Information and Knowledge Management, Proceedings",20,10.1145/1871437.1871533,Germany,Conference Paper,Koblenz am Rhein,0,Conference Proceeding,2-s2.0-78651265960
Sleigh S.,,Repurposing strategies for therapeutics,2010,Pharmaceutical Medicine,80,10.1007/BF03256811,United Kingdom,Note,Chichester,0,Journal,2-s2.0-77954813961
Munos B.,,Lessons from 60 years of pharmaceutical innovation,2009,Nature Reviews Drug Discovery,749,10.1038/nrd2961,United States,Review,Indianapolis,0,Journal,2-s2.0-73449101512
Noack A.,,Modularity clustering is force-directed layout,2009,"Physical Review E - Statistical, Nonlinear, and Soft Matter Physics",112,10.1103/PhysRevE.79.026102,Germany,Article,Cottbus,0,Journal,2-s2.0-60949111248
Chautard E.,,Interaction networks: From protein functions to drug discovery. A review,2009,Pathologie Biologie,82,10.1016/j.patbio.2008.10.004,France,Review,Villeurbanne,0,Journal,2-s2.0-67349200229
Conti-Fine B.M.,,"Myasthenia gravis: Past, present, and future",2006,Journal of Clinical Investigation,430,10.1172/JCI29894,United States,Review,Minneapolis,1,Journal,2-s2.0-33750575915
Harden C.L.,,"Hormone replacement therapy in women with epilepsy: A randomized, double-blind, placebo-controlled study",2006,Epilepsia,81,10.1111/j.1528-1167.2006.00507.x,United States;United States,Article,New York;New York,1,Journal,2-s2.0-33748692764
Chen X.Q.,,Discovery pharmaceutics - Challenges and opportunities,2006,AAPS Journal,41,10.1208/aapsj080246,United States,Short Survey,New York,0,Journal,2-s2.0-33745070265
Wishart D.S.,,DrugBank: a comprehensive resource for in silico drug discovery and exploration.,2006,Nucleic acids research,1791,10.1093/nar/gkj067,Canada,Article,Edmonton,1,Journal,2-s2.0-33644876210
Teo S.,,Thalidomide as a novel therapeutic agent: New uses for an old product,2005,Drug Discovery Today,114,10.1016/S1359-6446(04)03307-0,United States,Review,Summit,0,Journal,2-s2.0-13844256192
Gaertler M.,,Clustering,2005,Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics),40,10.1007/978-3-540-31955-9_8,,Conference Paper,,0,Book Series,2-s2.0-36849022530
Egan W.,,In silico prediction of drug safety: Despite progress there is abundant room for improvement,2004,Drug Discovery Today: Technologies,52,10.1016/j.ddtec.2004.11.002,United States;United States,Review,Boston;Cambridge,0,Journal,2-s2.0-13244277456
Brar S.S.,,"Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease",2004,Molecular Cancer Therapeutics,127,,United States,Article,Charlotte,0,Journal,2-s2.0-4644235752
Steeghs N.,,Cisplatin-induced encephalopathy and seizures,2003,Anti-Cancer Drugs,48,10.1097/00001813-200307000-00009,Netherlands;Netherlands,Article,Leiderdorp;Rotterdam,0,Journal,2-s2.0-0042126740
Wang X.,,"Complex networks: Small-world, scale-free and beyond",2003,IEEE Circuits and Systems Magazine,990,10.1109/MCAS.2003.1228503,China,Review,Shanghai,0,Journal,2-s2.0-0942276880
Navarro P.,,Penicillin degradation catalysed by Zn(II) ions in methanol,2003,International Journal of Biological Macromolecules,40,10.1016/S0141-8130(03)00081-3,Spain,Article,Granada,0,Journal,2-s2.0-0242409686
Newman M.,,The structure and function of complex networks,2003,SIAM Review,11537,10.1137/S003614450342480,United States,Review,Ann Arbor,0,Journal,2-s2.0-0038718854
Girvan M.,,Community structure in social and biological networks,2002,Proceedings of the National Academy of Sciences of the United States of America,8662,10.1073/pnas.122653799,United States;United States,Article,Santa Fe;Ithaca,1,Journal,2-s2.0-0037062448
Palace J.,,A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis,1998,Neurology,333,10.1212/WNL.50.6.1778,United Kingdom,Article,Oxford,0,Journal,2-s2.0-0031747483
Lee K.,,Potentiation of the pressor response to stress by tolbutamide in dogs,1993,Integrative Physiological and Behavioral Science,1,10.1007/BF02691197,United States,Article,Rochester,0,Journal,2-s2.0-0027356750
Hirohashi M.,,Pharmacological studies with the α<inf>2</inf>-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems,1991,Arzneimittel-Forschung/Drug Research,3,,Japan,Article,Tokyo,0,Journal,2-s2.0-0025965107
Fruchterman T.,,Graph drawing by force‐directed placement,1991,Software: Practice and Experience,2831,10.1002/spe.4380211102,United States;United States,Article,Urbana;Sunnyvale,0,Journal,2-s2.0-0026257928
Mikhailidis D.P.,,Platelet aggregation and thromboxane A<inf>2</inf> release in primary biliary cirrhosis and effect of D-penicillamine treatment,1988,"Prostaglandins, Leukotrienes and Essential Fatty Acids",3,10.1016/0952-3278(88)90109-3,United Kingdom,Article,London,0,Journal,2-s2.0-0023853061
Chang J.,,The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition,1987,European Journal of Pharmacology,27,10.1016/0014-2999(87)90108-7,United States,Article,New York,0,Journal,2-s2.0-0023572070
Khaw K.,,Dietary Potassium and Stroke-Associated Mortality,1987,New England Journal of Medicine,386,10.1056/NEJM198701293160502,United Kingdom;United States,Article,Cambridge;San Diego,0,Journal,2-s2.0-0023105455
Kawaguchi K.,,Tolbutamide Effect on Cultured Human Endothelial Cells with Special Reference to Platelet Aggregation,1983,The Tohoku Journal of Experimental Medicine,2,10.1620/tjem.141.Suppl_563,Japan,Article,Kumamoto,0,Journal,2-s2.0-0020979760
Valentovic M.,,"Impact of insulin or tolbutamide treatment on <sup>14</sup>C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats",1983,Diabetes,30,10.2337/diab.32.9.846,United States,Article,Lexington,0,Journal,2-s2.0-0020573259
